<DOC>
	<DOCNO>NCT00769938</DOCNO>
	<brief_summary>The study assess hypothesis combination warfarin &amp; clopidogrel 75 mg/day superior triple therapy ( warfarin + clopidogrel 75mg/day + aspirin 80mg/day ) respect bleed complication equally safe respect prevention thrombotic complication patient indication warfarin use dual antiplatelet ( clopidogrel 75mg/day + aspirin 80mg/day ) treatment .</brief_summary>
	<brief_title>WOEST ( What Optimal antiplatElet &amp; Anticoagulant Therapy Patients With Oral Anticoagulation Coronary StenTing )</brief_title>
	<detailed_description>Chronic oral antithrombotic treatment necessary patient mechanical heart valve majority patient atrial fibrillation . When patient undergo Percutaneous Coronary Intervention ( PCI ) stenting , also indication treatment aspirin clopidogrel . However , triple therapy know augment risk bleed complications.Unfortunately , prospective data available solve issue . Nevertheless , come find ideal therapy patient atrial fibrillation percutaneous intervention prevent thrombotic complication ( e.g . stent thrombosis ) without increase risk bleeding . This prospective randomise study assess hypothesis patient warfarin therapy indication elective percutaneous intervention , combination warfarin &amp; clopidogrel 75 mg/day superior triple therapy treatment reduce risk bleeds equally safe respect prevention thrombotic complication</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>Patients oral anticoagulation therapy continue throughout period 1 yearand deployment least 1 coronary stent ( bare metal stent ( BMS ) drug elute stent ( DES ) ) . age 18 year cardiogenic shock , contraindication aspirin clopidogrel allergy aspirin clopidogrel , document peptic ulcer disease within previous six month , pregnancy previous intracerebral haemorrhage significant thrombocytopenia ( platelet count &lt; 50x10 9/L ) . major bleed accord timi criterion within past 12 month age &gt; 80 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Atrial fibrillation</keyword>
	<keyword>Percutaneous coronary stenting</keyword>
	<keyword>Bleeding complication</keyword>
	<keyword>Triple therapy</keyword>
</DOC>